{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:50:49Z","timestamp":1781200249309,"version":"3.54.1"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>About one-third of multiple myelomas produce excess free monoclonal light chains. Detection of monoclonal light chains is important for diagnosis, prognosis, and monitoring of such lesions. A previously described method for detection of monoclonal light chains in serum required multiple manual wash steps. Even though the method has sensitivity similar to that of mass spectrometry, the manual wash steps were a hindrance to the method\u2019s widespread use.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>To mitigate the laborious nature of the previous method, the SPIFE Nexus instrument (Helena Laboratories) was modified to automate the sample application, electrophoretic separation, antibody application, washing and blotting steps needed for removal of background proteins. Background noise was mitigated by modifying the wash buffer by adding a detergent. This revised automated electrophoresis protocol was tested in parallel with the previously described method.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The sensitivity and specificity of the modified method using antisera to free light chains from 2 sources was comparable to the parameters of the previously described method without the need for manual manipulation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>The automated protocol employing the SPIFE Nexus instrument and incorporating antisera to free light chains is suitable for routine use in clinical laboratories in an automated, enhanced-sensitivity assay for monoclonal light chains with no need for manual manipulation.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/labmed\/lmaf014","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T21:36:44Z","timestamp":1748209004000},"page":"536-540","source":"Crossref","is-referenced-by-count":2,"title":["Automated detection of free monoclonal light chains by enhanced-sensitivity modified immunofixation electrophoresis with antisera against free light chains"],"prefix":"10.1093","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0621-7254","authenticated-orcid":false,"given":"Gurmukh","family":"Singh","sequence":"first","affiliation":[{"name":"Department of Pathology, Medical College of Georgia at Augusta University , Augusta, GA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily J","family":"Salda\u00f1a","sequence":"additional","affiliation":[{"name":"Helena Laboratories Inc , Beaumont, TX ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Spencer","sequence":"additional","affiliation":[{"name":"Helena Laboratories Inc , Beaumont, TX ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roni J","family":"Bollag","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical College of Georgia at Augusta University , Augusta, GA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"key":"2025090821520802900_CIT0001","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1093\/jnci\/djab131","article-title":"Annual report to the nation on the status of cancer, Part 1: National Cancer Statistics","volume":"113","author":"Islami","year":"2021","journal-title":"J Natl Cancer Inst."},{"key":"2025090821520802900_CIT0002","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","article-title":"Multiple myeloma","volume":"397","author":"van de Donk","year":"2021","journal-title":"Lancet."},{"key":"2025090821520802900_CIT0003","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa2405090","article-title":"Belantamab mafodotin, bortezomib, and dexamethasone for multiple myeloma","volume":"391","author":"Hungria","year":"2024","journal-title":"N Engl J Med."},{"key":"2025090821520802900_CIT0004","doi-asserted-by":"publisher","first-page":"46","DOI":"10.14740\/jocmr2802w","article-title":"Serum free light chain assay and \u03ba\/\u03bb ratio: performance in patients with monoclonal gammopathy-high false negative rate for \u03ba\/\u03bb ratio","volume":"9","author":"Singh","year":"2017","journal-title":"J Clin Med Res."},{"key":"2025090821520802900_CIT0005","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1093\/jalm\/jfaa153","article-title":"Serum and urine protein electrophoresis and serum-free light chain assays in the diagnosis and monitoring of monoclonal gammopathies","volume":"5","author":"Singh","year":"2020","journal-title":"J Appl Lab Med."},{"key":"2025090821520802900_CIT0006","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol."},{"key":"2025090821520802900_CIT0007","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1093\/jalm\/jfab090","article-title":"Light chain multiple myeloma: high serum free light chain concentrations portend renal damage and poorer survival","volume":"6","author":"Jin","year":"2021","journal-title":"J Appl Lab Med."},{"key":"2025090821520802900_CIT0008","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/labmed\/lmab001","article-title":"Analysis of multiple bands on serum protein immunofixation electrophoresis: challenge in interpretation of clonality in a patient with light chain predominant multiple myeloma","volume":"52","author":"Nwogbo","year":"2021","journal-title":"Lab. Med."},{"key":"2025090821520802900_CIT0009","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/labmed\/lmab054","article-title":"Light chain-predominant multiple myeloma subgroup: impaired renal function correlates with decreased survival","volume":"53","author":"Singh","year":"2022","journal-title":"Lab. Med.."},{"key":"2025090821520802900_CIT0010","first-page":"143","article-title":"Free monoclonal immunoglobulin light chains in serum and urine. 21st Century","volume":"3","author":"Singh","year":"2023","journal-title":"Pathology (Phila)."},{"key":"2025090821520802900_CIT0011","first-page":"134","article-title":"Monoclonal light chains in multiple myeloma: the sinister immunoglobulin","volume":"8","author":"Singh","year":"2022","journal-title":"Int J Pathol Clin Res"},{"key":"2025090821520802900_CIT0012","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/labmed\/lmy067","article-title":"Concentrations of serum free light chains in \u039a and \u039b lesions in light-chain myelomas","volume":"50","author":"Singh","year":"2019","journal-title":"Lab. Med.."},{"key":"2025090821520802900_CIT0013","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/labmed\/lmz007","article-title":"Serum free light chain assay in monoclonal gammopathic manifestations","volume":"50","author":"Lee","year":"2019","journal-title":"Lab. Med."},{"key":"2025090821520802900_CIT0014","doi-asserted-by":"publisher","first-page":"671","DOI":"10.14740\/jocmr3049w","article-title":"Oligoclonal pattern\/abnormal protein bands in post-treatment plasma cell myeloma patients: implications for protein electrophoresis and serum free light chain assay results","volume":"9","author":"Singh","year":"2017","journal-title":"J Clin Med Res."},{"key":"2025090821520802900_CIT0015","first-page":"79","article-title":"Urine protein electrophoresis and immunofixation electrophoresis supplement one another in characterizing proteinuria","volume":"30","author":"Levinson","year":"2000","journal-title":"Ann Clin Lab Sci."},{"key":"2025090821520802900_CIT0016","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/labmed\/lmac155","article-title":"Urine protein immunofixation electrophoresis: free light chain urine immunofixation electrophoresis is more sensitive than conventional assays for detecting monoclonal light chains and could serve as a marker of minimal residual disease","volume":"54","author":"Singh","year":"2023","journal-title":"Lab. Med."},{"key":"2025090821520802900_CIT0017","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/labmed\/lmaa012","article-title":"Quantification by ultrafiltration and immunofixation electrophoresis testing (QUIET) for monoclonal serum free light chains","volume":"51","author":"Singh","year":"2019","journal-title":"Lab. Med."},{"key":"2025090821520802900_CIT0018","doi-asserted-by":"publisher","first-page":"e00256","DOI":"10.1016\/j.plabm.2021.e00256","article-title":"Multiple myeloma: detection of free monoclonal light chains by modified immunofixation electrophoresis with antisera against free light chain","volume":"27","author":"Wilhite","year":"2021","journal-title":"Pract Lab Med."},{"key":"2025090821520802900_CIT0019","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1515\/cclm-2020-0581","article-title":"Automation and validation of a MALDI-TOF MS (Mass-Fix) replacement of immunofixation electrophoresis in the clinical lab","volume":"59","author":"Kohlhagen","year":"2020","journal-title":"Clin Chem Lab Med."},{"key":"2025090821520802900_CIT0020","volume-title":"Serum Free Light Chain Analysis (Plus Hevylite)","author":"Bradwell","year":"2015","edition":"7"},{"key":"2025090821520802900_CIT0021","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/clinchem\/48.9.1437","article-title":"Serum reference intervals and diagnostic ranges for free \u03ba and free \u03bb immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains","volume":"48","author":"Katzmann","year":"2002","journal-title":"Clin Chem."},{"key":"2025090821520802900_CIT0022","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.4065\/81.12.1575","article-title":"Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays","volume":"81","author":"Katzmann","year":"2006","journal-title":"Mayo Clin Proc."},{"key":"2025090821520802900_CIT0023","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/ajcp\/aqw099","article-title":"Serum free light chain assay and \u03ba\/\u03bb ratio: performance in patients without monoclonal gammopathies \u2013 High false positive rate","volume":"146","author":"Singh","year":"2016","journal-title":"Amer J Clin Pathol"},{"key":"2025090821520802900_CIT0024","doi-asserted-by":"publisher","first-page":"562","DOI":"10.14740\/jocmr3383w","article-title":"Serum free light chains in neoplastic monoclonal gammopathies: Relative under-detection of \u03bb dominant \u03ba\/\u03bb ratio, and underproduction of free \u03bb light chains, as compared to \u03ba light chains, in patients with neoplastic monoclonal gammopathies","volume":"10","author":"Lee","year":"2018","journal-title":"J Clin Med Res."},{"key":"2025090821520802900_CIT0025","doi-asserted-by":"publisher","first-page":"e0166841","DOI":"10.1371\/journal.pone.0166841","article-title":"Prognostic value of serum free light chains measurements in multiple myeloma patients","volume":"11","author":"Garc\u00eda de Veas Silva","year":"2016","journal-title":"PLoS One."},{"key":"2025090821520802900_CIT0026","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41408-024-00995-y","article-title":"Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry","volume":"14","author":"Giles","year":"2024","journal-title":"Blood Cancer J."}],"container-title":["Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/56\/5\/536\/63350158\/lmaf014.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/56\/5\/536\/63350158\/lmaf014.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T01:52:12Z","timestamp":1757382732000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/labmed\/article\/56\/5\/536\/8148745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,24]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,24]]},"published-print":{"date-parts":[[2025,9,8]]}},"URL":"https:\/\/doi.org\/10.1093\/labmed\/lmaf014","relation":{},"ISSN":["0007-5027","1943-7730"],"issn-type":[{"value":"0007-5027","type":"print"},{"value":"1943-7730","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,5,24]]}}}